Tag: NASDAQ:INMB

September 12, 2019

5 Alzheimer’s Disease Treatment Stocks on the NASDAQ

A report from Reports and Data suggests the overall Alzheimer's market will be worth US$12.43 billion by 2026.
September 12, 2019

INmune Bio Gets US Patent for DN-TNFa Platform

INmune Bio (NASDAQ:INMB) has announced that the US Patent and Trademark Office has granted the company Patent Application Serial  No....
May 15, 2019

INmune Bio Reports First Quarter 2019 Financial Results

INmune Bio (NASDAQ:INMB) has reported its financial results for the first quarter ended March 31, 2019. As quoted in the...
April 16, 2019

Biotech Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a biotech market update on the biggest news and trends...